Yongping Song
- Oncology top 5%
- CAR-T cell therapy research 8
- Cancer Immunotherapy and Biomarkers 6
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 5
- Immunology top 5%
- Immune Cell Function and Interaction 7
- Immunotherapy and Immune Responses 6
- Cancer Research top 10%
-
- PI3K/AKT/mTOR signaling in cancer 3
- Cancer therapeutics and mechanisms 3
-
- Lymphoma Diagnosis and Treatment 3
- Cited by
- OncologyGeneticsImmunology
- Partner nations
- ChinaUnited StatesNorway
In The Last Decade
Yongping Song
26 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 84
- Oncology 717
- Genetics 223
- Immunology 440
- Cancer Research 256
- Pulmonary and Respiratory Medicine 459
Countries citing papers authored by Yongping Song
This map shows the geographic impact of Yongping Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongping Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongping Song more than expected).
Fields of papers citing papers by Yongping Song
This network shows the impact of papers produced by Yongping Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongping Song. The network helps show where Yongping Song may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yongping Song, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2022 | 9 | |
| 4 | 2021 | 4 | |
| 5 | 2020 | 1 | |
| 6 | 2020 | 22 | |
| 7 | 2020 | 46 | |
| 8 | 2019 | 24 | |
| 9 | 2019 | 33 | |
| 10 | 2017 | 89 | |
| 11 | DDX51 gene promotes proliferation by activating Wnt/β-catenin signaling in breast cancer. | 2017 | 3 |
| 12 | 2017 | 25 | |
| 13 | 2016 | 236 | |
| 14 | 2016 | 78 | |
| 15 | 2016 | 31 | |
| 16 | 2015 | 221 | |
| 17 | 2015 | 3 | |
| 18 | 2013 | 219 | |
| 19 | 2012 | 174 | |
| 20 | Evaluation on the safety of structured triglyceride in hematopoietic stem cell transplantation | 2010 | 1 |
About Yongping Song
Yongping Song is a scholar working on Oncology, Genetics and Immunology, having authored 28 papers that have together received 1.7k indexed citations. Recurring topics across this work include CAR-T cell therapy research (8 papers), Immune Cell Function and Interaction (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Immunotherapy and Immune Responses (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Cancer therapeutics and mechanisms (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Oncology (717 citations), Genetics (223 citations) and Immunology (440 citations). Yongping Song has collaborated with scholars based in China, United States and Norway. Frequent co-authors include Delong Liu, Shuhang Wang, Shuhang Wang, Anping Li, Ming Yi, Shuang Qin, Kongming Wu, Qian Chu, Shundong Cang and Chaitanya Iragavarapu.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.